Preventive care for the patients with chronic kidney disease in the Russian Federation: analytical review of the prevalence and existing programs

Bibliography:
1 Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Inter 2012; 2; 335
2 National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases 2002; 39 (2); 1-266
3 K/DOQI Clinical practice guidelines for chronic kidney disease: assessment, classification and stratification. URL: http://www.diaiysis.ru/standard/doqi-ckd/ g7.htm
4 Shilov ЕМ, Shvetsov MYu, Bobkova IN, et al. Chronic kidney disease and nephroprotective therapy: methodical guide for doctors. Moscow, 2012; 76 p.
5 Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major non-communicable diseases. Kidney Int 2011; 80; 1258-70
6 Go AS, ChertowGM, Fan D, McCulloch CE, Hsu О Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.7 Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 2012; 380: 807-14
8 GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 Lancet 2016; 388: 1603-58
9 Weber C, Beaulieu M, Djurdjev O, et al. Towards rational approaches of health care utilization in complex patients: an exploratory randomized trial comparing a novel combined clinic to multiple specialty clinics in patients with renal disease-cardiovascular disease-diabetes. Nephrol Dial Transplant 2012; 27: 104-10
10 Lee H, Manns B, Taub K, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 2002; 40:611-22
11 Obrezan AG, Zemchenkov AYu. Chronic kidney disease as the basis for an increased risk of hemorrhagic and thrombotic complications in patients with atrial fibrillation: the place of oral anticoagulants. Cardiology 2018; 58 (4):60-70
12 Kobalava ZD, Villevalde SV, Bagmanova NKh, Batyushin MM, Orlova GM. The prevalence of markers of chronic kidney disease in patients with arterial hypertension, depending on the presence of diabetes mellitus: the results of an epidemiological study of chronographs. Russian Journal of Cardiology 2018; 2 (154): 1-101
13 Following the Political Declaration on Non-communicable Diseases (NCDs) adopted by the UN General Assembly in 2011 URL: http://www.euro.who.int/ru/health-topics/ health-policy/health-2020-the-european-policy-for- health-and-well-being (date of circulation: 25.02.2019
14 Benghanem GM, Elseviers M, Zamd M, et al. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid 'over' — and 'under' — diagnosis of CKD. Kidney Int 2016; (89): 1363- 71 15 Shahinian VB, Hedgeman E, Gillespie BW, et al. Estimating prevalence of CKD stages 3-5 using health system data. Am J Kidney Dis 2013; 61 (6): 930-8
16 Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-47
17 Smirnov AV, Dobronravov VA, Kayukov IG, Bodur-OorzhakASh, Yesayan AM, KucherAG. Epidemiology and socio-economic aspects of chronic kidney disease. Nephrology 2006; 10 (1): 7-13
18 Nagaitseva SS, Shvetsov MYu, Shalyagin YuD, Pyagay NL, Ivanova ES, Shilov EM. Risk factors for increasing albuminuria as an early marker of chronic kidney disease in different age groups. Nephrology 2013; 17 (4): 58-62
19 Shutov AM, Serov VA. Cardiorenal continuum or cardiorenal syndrome? Clinical Nephrology 2010; 1: 44-8
20 White SL, Polkinghorne KR, Cass A, Shaw J, Atkins RC, Chadban SJ. Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust 2008; 188 (4): 204-8
21 Order of the Ministry of Health of Russia of December 21, 2012 No.1344n "On approval of the procedure for conducting follow-up care" (Registered in the Ministry of Justice of Russia on February 14, 2013 No.27072)
22 Order of the Ministry of Health of Russia of January 18, 2012 No.17n "Ob utverzhdenii poryadka okazaniya meditsinskoy pomoschi vzroslomu naseleniyu po profilyu nefrologiya" (Registered in the Ministry of Justice of Russia on March 12, 2012 No. 23446)
23 Bikbov ВТ, Tomilina NA. Replacement therapy for terminal chronic renal failure in the Russian Federation in 1998-2013: Report on the Russian register of renal replacement therapy: Part one. Nephrology and dialysis 2015; 7 (3): 5-101
24 Tomilina NA, Andrusev AM, Peregudova NG, Shinkarev MB. Replacement therapy for terminal chronic renal failure in the Russian Federation in 2010-2015: Report according to the All-Russian Registry of Renal Replacement Therapy of the Russian Dialysis Society: Application. Nephrology and dialysis 2017; 19 (4): 94
25 ERA-EDTA Registry: ERA-EDTA Registry 2013 Annual Report. Academic Medical Center, Amsterdam, The Netherlands, 2015; 148 p.
26 US Renal Data System, USRDS 2014 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda.MD, 2014